#NACD
and to your first question, youre free to peruse the annual reports from various industry groups on your own time, NACD and transre are good starting points. the findings, generally, are: large cap cos buy at a higher rate than smaller cap
November 15, 2026 at 3:10 PM
The Economics Of Attention, Joshua White, Chief Economist And Director, Division Of Economic And Risk Analysis, National Association Of Corporate Directors (NACD), Nashville, Brentwood, TN, Nov. 11, 2026
Thank you, Ed (Magee), and good afternoon. It is a pleasure to be here with the NACD Nashville Chapter.1 Before I begin, let me give our standard disclaimer. My remarks are provided in my official capacity as the Chief Economist and Director of the Division of Economic and Risk Analysis but do not necessarily reflect the views of the Commission, the Commissioners, or other members of the staff. It is good to be back in Middle Tennessee. Some of the research I want to talk about today was done just up I-65 at Vanderbilt. However, I want to start with something from NACD’s own research. In its 2026 Governance Outlook survey, directors were asked which trends they expected to have the greatest impact on their companies over the next year. The top three were shifting economic conditions, “artificial intelligence” (also known as superintelligence or SI), and regulatory requirements.2 I am not going to try to cover the economy this afternoon. But I am an economist, so I thought I would talk about the economics of the other two. Regulation and SI may seem very different. But they have something important in common: both can change how companies use scarce resources. They can change what things cost, how people spend their time, and ultimately where capital and attention go. And for a board, attention may be the scarcest resource of all. As Dolly Parton reminded us in “9 to 5,” the workday has limits.3 Directors, of course, work well past five. But the day itself does not get any longer. There are still only 24 hours, and every hour spent on one thing is an hour that cannot be spent on something else.  Economists call that opportunity cost. And the more things competing for a board’s attention, the more that cost matters. That is really what I want to talk about today: the economics of attention. I will talk about how we think about those tradeoffs at the SEC, what we can learn from one regulatory experiment, and what SI might change. The JOBS Act Let me start with the biotech companies. Imagine a small biotech startup with a promising drug candidate and no revenue. It may be years before that company has a product to sell. In the meantime, nearly everything it does depends on outside capital. It has to hire scientists. Build laboratories. Run clinical trials. Develop intellectual property. Navigate the FDA approval process. Those things are expensive. And that means every dollar the company spends on something else, like compliance, is a dollar that cannot be spent on the science. In 2012, Congress passed the JOBS Act. Among other things, it created an on-ramp for emerging growth companies entering the public markets. For a period after going public, eligible companies could use scaled disclosure requirements and were exempt from auditor attestation of internal controls under Section 404(b) of Sarbanes-Oxley. For an economist, this created somewhat of a natural experiment to ask what biotech companies did with the compliance relief?4 The answer was interesting. Biotech IPO activity increased after the JOBS Act. The companies coming public were earlier in the FDA approval process, and they were more likely to pursue treatments for cancer and rare diseases. But what happened after the IPO was even more interesting. Research has found that these companies produced more patents. They conducted more clinical trials. They staffed more laboratories. Their drug candidates were more likely to reach important milestones in the FDA approval process. And the companies failed at lower rates. In a survey, biotech executives themselves were pretty straightforward about what they did with the savings: they said they invested more in research and development. In other words, reducing one use of resources allowed companies to put more resources somewhere else. And in this case, somewhere else was science. There is one other result that matters. The research did not find evidence that financial reporting quality declined. That is important because reducing a regulatory cost is not much of a gain if it simply creates a larger cost somewhere else. Here, the evidence suggests the opposite: the relief freed up resources that these young companies put back into the science. SEC Cost-Benefit Analysis And that brings me to how economists at the SEC think about these tradeoffs. Every significant rule the Commission considers comes with an economic analysis.5  At a basic level, the Commission asks a few questions that will sound familiar to anyone who has sat through a capital allocation discussion.  What problem are we trying to solve?  What does the world look like today?  What alternatives are available?  And what benefits and costs could follow if the Commission acts? Congress has also directed the Commission to consider, alongside investor protection, whether its rules promote efficiency, competition, and capital formation. Let me spend a minute on efficiency, because that connects to board attention. Economists use the term productive efficiency to describe getting more value from the resources you have. And those resources include more than money. They include people, management time, technology, and board attention. Companies can use all of these when complying with regulation. A compliance requirement may require new systems, outside advisers, additional employees, management meetings, and board oversight. And those resources can produce something valuable. Disclosure can reduce information gaps between companies and investors and help investors better evaluate risk and allocate capital. And companies can benefit from that too. Better information can reduce uncertainty and, in some cases, lower the cost of raising capital. So the economic question is not whether disclosure has value. It clearly can. The question is whether the value of the information produced justifies the resources and other costs required to produce it.  And that balance can change as technology and markets evolve. And, in those cases, simplifying or eliminating a requirement can reduce the resources devoted to compliance and free them for other uses. That is an efficiency gain. And what happens to the resources that are freed up matters. A dollar no longer spent on a requirement that can be simplified or eliminated can be invested in a new product, a new store, better technology, or a more efficient supply chain.  An hour that management no longer spends on a compliance process can be spent running the business. And an hour the board no longer spends overseeing that process can be spent on strategy, capital allocation, succession, or risk. If those resources create more value in their new use, the company is getting more from the same dollars and the same hours. That is productive efficiency in a very practical sense. It is also why the opportunity cost of regulation matters. Compliance does not just have a price tag. It occupies resources that could have been used somewhere else. For directors, that resource is often time and attention. A board can devote substantial time to compliance and have too little time left for other important decisions.  Many of the rules the Commission is considering today are deregulatory. The potential benefit is not deregulation for its own sake. It is freeing resources so they can be put to better use somewhere else. But the economic analysis the Division of Economic and Risk Analysis produces still has to consider what the requirement was doing.  If removing it reduces investor protection, eliminates information investors value, or requires firms to unwind systems they have already built, those effects matter too.  Deregulation is subject to the same economic discipline as a new regulation. And efficiency is only one part of that analysis. The same regulatory costs can also affect competition and capital formation. Fixed compliance costs can fall more heavily on smaller firms and affect entry and competition.  And the cost of regulation can affect whether companies raise capital, where they raise it, and whether becoming or remaining a public company makes economic sense. Which brings us back to biotech. The study I mentioned earlier gives us a concrete example of what productive efficiency can look like. The JOBS Act reduced some of the resources these young companies had to devote to compliance. They did not simply pocket the savings. They redeployed resources into the business, hiring scientists, running clinical trials, and developing drugs. And we did not find a detectable decline in financial reporting quality. In other words, they spent less on compliance and more on their science. Their investors benefited. And if those additional investments ultimately produce therapies that reach patients, society may benefit as well. Commenters Let me make one more point about the Commission’s own work. The SEC has access to an enormous amount of information. But we cannot observe everything. People in this room know things about operating companies that we cannot readily learn from a filing. You know which compliance costs involve a one-time build and which recur every year. You know which requirements can be incorporated into an existing system and which require building something new. You know which issues consume management attention. You know which ones reach the board. That kind of information can be enormously valuable to economic analysis. So I encourage you, your companies, and your trade groups to comment on Commission proposals. When you do, data help. Tell us what something costs. Tell us what drives the cost. Tell us who ultimately bears it. And tell us how behavior is likely to change. That is the kind of information that makes the Commission’s analysis better. SuperIntelligence That brings me to the other disruptor on today’s agenda: super intelligence. SI brings us right back to efficiency. NACD’s survey found that 76 percent of directors expect SI to factor into their companies’ growth strategies. But so far, most companies report only slight or moderate success in achieving operational efficiencies from those investments.  SI can lower the cost of processing information. It can search, summarize, compare, and analyze enormous amounts of information much faster than people can. And it may lower some of the costs of producing information as well. But lower costs do not mean the answer is simply to produce more of everything. I made this point in September when I spoke to fund compliance professionals.6 If SI makes disclosure easier to process, it can be tempting to conclude that companies should simply disclose more.  But information still has to be collected, verified, reconciled, and ultimately stood behind. SI may reduce the cost of processing information. It does not make reliable information free to produce. And there is an opportunity cost to producing it. Every hour management spends collecting and verifying immaterial information that investors do not need is an hour that cannot be spent running the business. Every hour a board spends overseeing that process is an hour that cannot be spent on strategy, capital allocation, succession, or risk. That is one reason a principles-based standard like materiality matters so much. Materiality focuses disclosure on the information that matters to investors. It does not ask them to disclose something simply because technology has made it possible to produce it.  The SEC’s disclosure framework has long treated materiality as a central organizing principle, and SI does not eliminate the economic considerations behind it. In fact, you can make an efficiency argument for keeping that discipline. If SI allows a management team to produce a disclosure in three days instead of three weeks, the goal should not necessarily be to fill the other two and a half weeks producing more disclosure. There is an opportunity to give some of that time back to the people running the company if that is a better use of the resources. Let them spend it developing a new product. Improving the supply chain. Talking to customers. Finding a better investment. Talking to investors. Or doing whatever else creates value for that particular company. That is the same reallocation we saw in the JOBS Act study: resources freed from one use could be put to use somewhere else. SI creates the same possibility. So for a board, I think there are two important questions.  Is SI allowing the company to do necessary work more efficiently?  And, just as important, what is the company doing with the time and resources it gets back? Because the promise of SI is not an endless amount of output. It is the opportunity to devote scarce resources, especially human attention, to the things that matter most. Closing And it brings me back to where I started. Boards face a scarce-resource problem every time they set an agenda. So do companies every time they decide where to invest. And regulators face one whenever a rule causes resources to move from one use to another. The question is not simply whether something has a cost. The better question is what we are getting for that cost, and what those resources could be doing instead. For the biotech companies, some of the answer was science. For every company represented in this room, the answer will be different. Figuring out where those scarce resources should go is an important job for boards, and for regulators trying to get the rules right. Thank you. I look forward to the conversation with Jan, Kurt, and Kim. * 1See https://www.nacdonline.org/nashville/nashville-events/navigating-regulatory-and-technology-disruptors. * 2Seehttps://www.nacdonline.org/all-governance/governance-resources/governance-research/outlook-and-challenges/2026-governance-outlook/boards-shift-their-focus-to-execution/. * 3Dolly Parton, “9 to 5” (RCA Records 1980). * 4See Lewis, C. M., & White, J. T. (2023). Deregulating innovation capital: The effects of the JOBS Act on biotech startups. The Review of Corporate Finance Studies, 12(2), 240-290. * 5See https://www.sec.gov/divisions/riskfin/rsfi_guidance_econ_analy_secrulemaking.pdf. * 6See https://www.sec.gov/newsroom/speeches-statements/white-remarks-ici-compliance-091726.
dlvr.it
November 12, 2026 at 1:03 PM
Paul and Diane Overby named Soil Health Champions – Agweek

https://www.byteseu.com/2518993/

A North Dakota couple recently was named Soil Health Champions by the National Association of Conservation Districts. The Rolette County Soil Conservation District worked with the NACD to nominate Paul …
Paul and Diane Overby named Soil Health Champions - Agweek - Bytes Europe
A North Dakota couple recently was named Soil Health Champions by the National Association of Conservation Districts.
www.byteseu.com
November 13, 2026 at 12:13 PM
youtube.com/watch?v=NaCD...
NYC Brooklyn iligal immigrants pastors all say Office Adam Schiff will carry out Pete impeachment this week.
Republicans Move to Impeach Hegseth: What Happens Next?
YouTube video by American Election Watch
youtube.com
November 9, 2026 at 8:05 AM
One great party sparked a whole new community! Brandon of PAN and Timmy of NACD join TNV Live to talk friendship, building naturist clubs, welcoming newcomers, and the moments that started it all. Plus, games and an SCNA spotlight!

Episode out now! Listen wherever you stream podcasts!
October 31, 2026 at 6:45 PM
Great reconnecting with my good friend Khwaja Shaik at the NACD Directors Summit! I enjoyed his discussion with Harry Kraemer Jr. on the importance of values-based leadership in the boardroom. Grateful for Khwaja's friendship and endorsement of my book, Make Your Destiny Happen!

#BoardLeadership
October 28, 2026 at 10:03 PM
Recent stops: Stanford ETL, the NACD Directors Summit, a fireside with Janet Napolitano at Inc. 5000, and a conversation with Krista Tippett at Masters of Scale. Next: UC Berkeley's Newton Lecture, Tuesday 10/27, 5pm PT on Zoom. howisincorruptiblegoing.com/events/
October 24, 2026 at 10:00 PM
#DailyMusic 2026.10.24
m.youtube.com/watch?v=naCd...
2026-10-24
【【官方投稿】薛定谔的我(Schrodinger's Me)feat. 重音テト, GUMI-哔哩哔哩】 b23.tv/DftZPgg
Chenomio - シュレディンガーズ・ミー feat.重音テト, GUMI
YouTube video by Chenomio
m.youtube.com
October 23, 2026 at 7:00 PM
What an incredible experience at the NACD Directors Summit! 🙏🏾

Grateful to connect with fellow board directors and governance leaders, exchange perspectives, and explore the challenges facing today's boards. Looking forward to carrying these insights forward!

#NACDSummit #DDDLeadership
October 23, 2026 at 5:00 AM
New PCS Podcast with #corpgov veterans Alex Reed Lajoux (NACD) and Larry Cunningham (Weinberg Center). Is governance at an inflection point? Are directors professionals in all but name?

Listen and follow. And leave a review!

www.publiccompanyseries.com/podcast/08kx...
The Changing Governance Landscape: Shifting Power, Systemic Risk, and Board Professionalism [UD & CES] — The Public Company Series
Episode Description Has the corporate governance landscape reached a pivotal turning point, or are we simply witnessing another incremental adjustment? In this episode, Doug Chia speaks with Alexan...
www.publiccompanyseries.com
October 20, 2026 at 6:35 PM
Great day at the NACD Directors Summit yesterday. Tatyana Mamut, a board director who was there: "This feels like a potential seismic shift in Corporate Governance." Photos: Tatyana Mamut, Rebecca Cooke. www.nacdonline.org/nacd-events/...
October 14, 2026 at 5:31 PM
At the NACD Directors Summit today, speaking on the main stage this morning about Incorruptible. Say hi if you're there. www.nacdonline.org/nacd-events/...
October 13, 2026 at 12:45 PM
The Pentagon plans to execute Nidal Hasan by firing squad and livestream his death. The National Association of Criminal Defense Lawyers warned the broadcast will revive a history of public executions.

davisvanguard.org/2026/10/nacd...
October 12, 2026 at 8:00 PM
Tomorrow morning I'm speaking at the NACD Directors Summit outside Washington, DC. Ahead of it, here's what board directors and chairs have said about Incorruptible. www.nacdonline.org/nacd-events/...
October 12, 2026 at 5:30 PM
NACD's 2026 Blue Ribbon Commission Offers New Framework for Board Oversight of Strategy Execution#USA#Washington_D.C.#Governance#NACD#Board_Strategy
NACD's 2026 Blue Ribbon Commission Offers New Framework for Board Oversight of Strategy Execution
The NACD's 2026 Blue Ribbon Commission report introduces a new framework for boards to effectively oversee strategy execution amidst rapid changes.
third-news.com
October 12, 2026 at 3:44 PM
Fun two yoga practices
with the people from Naked Adventure Club Detroit diringntheir lodge takeover at Turtle Lake
the next event is Full Moon Hallopalooza
www.getnacd.org
Naked Adventure Club of Detroit (NACD)
www.getnacd.org
October 11, 2026 at 4:38 PM
The Pentagon plans to execute Nidal Hasan by firing squad and livestream his death. The National Association of Criminal Defense Lawyers warned the broadcast will revive a history of public executions.

davisvanguard.org/2026/10/nacd...
NACDL Condemns Pentagon Plan to Livestream Military Execution, Raising Due Process and Human Dignity Concerns - Davis Vanguard
The National Association of Criminal Defense Lawyers (NACDL) expressed opposition to the Pentagon's proposal to execute Nidal Hasan via firing squad and broadcast the event, citing substantial concern...
davisvanguard.org
October 12, 2026 at 12:35 PM
Teaching the same founders at NACD, Inc. 5000 and MIT in one month is a heavy load. Which idea from The Lean Startup do you see boards still resisting most?
October 9, 2026 at 11:30 PM
My October.

Keynotes: NACD Directors Summit (Oct 13) → Inc. 5000 (Oct 15) → Masters of Scale (Oct 22)

Classrooms: IAE Business School (Oct 2) → MIT Sloan (Oct 5) → Duke (Oct 6) → Stanford ETL (Oct 7) → B Academics (Oct 23) → UC Berkeley (Oct 27)
October 9, 2026 at 9:45 PM
Next Tuesday (October 13) I'm giving a main stage talk on Incorruptible at the NACD Directors Summit, the annual meeting of the National Association of Corporate Directors. If you'll be there, let's say hello. www.nacdonline.org/nacd-events/...
October 6, 2026 at 9:00 PM
Nextdoor congratulated Elisa Steele on making the NACD Directorship 100.

So I read the governance criteria: courage under duress, shareholder value, accountability—and keeping ego in check.

Excellent standards. Now apply them.

Nirav, blocking questions doesn’t answer them. 😂

👉 NielFlamm.com/blog
October 5, 2026 at 12:02 AM
Experience alone isn’t enough anymore. On the new episode of the Public Company Series, NACD’s Marcel Bucsescu and I discuss continuous learning for directors, board refreshment, and how AI is changing both what boards need to learn and how they work. #corpgov publiccompanyseries.com/podcast/the-...
The Future-Ready Director: AI, Cybersecurity, and Execution Oversight [NACD] – Public Company Series Podcast
publiccompanyseries.com
September 29, 2026 at 4:30 PM
JOB OPENING: Grants Administrator: Grants Administrator
$65,000 - $75,000 per year -- National Association of Conservation Districts’ (NACD)
Grants Administrator
Grants Administrator $65,000 - $75,000 per year -- National Association of Conservation Districts’ (NACD)
dlvr.it
September 14, 2026 at 1:01 PM